|
|
Volumn 36, Issue 3, 2007, Pages 245-253
|
|
Neurogenesis and neuroprotection in the CNS - Fundamental elements in the effect of glatiramer acetate on treatment of autoimmune neurological disorders
a
|
|
Author keywords
Brain derived neurotrophic factor (BDNF); Experimental autoimmune encephalomyelitis (EAE); Glatiramer acetate (GA); Immunomodulation; Multiple sclerosis (MS); Neurogenesis; Neuroprotection; Neurotrophic factors (NTs)
|
|
Indexed keywords
GLATIRAMER;
IMMUNOLOGICAL ADJUVANT;
IMMUNOSUPPRESSIVE AGENT;
PEPTIDE;
BLOOD BRAIN BARRIER;
BRAIN REGION;
CELL PROLIFERATION;
CENTRAL NERVOUS SYSTEM;
DRUG EFFECT;
HUMAN;
IMMUNE RESPONSE;
IMMUNOHISTOCHEMISTRY;
IMMUNOMODULATION;
MULTIPLE SCLEROSIS;
NERVE CELL;
NERVOUS SYSTEM DEVELOPMENT;
NEUROPROTECTION;
NONHUMAN;
REVIEW;
STEM CELL;
T LYMPHOCYTE;
ANIMAL;
AUTOIMMUNE DISEASE;
BRAIN;
IMMUNOLOGY;
INFLAMMATION;
NERVE DEGENERATION;
NEUROLOGIC DISEASE;
PATHOLOGY;
PATHOPHYSIOLOGY;
PHYSIOLOGY;
ADJUVANTS, IMMUNOLOGIC;
ANIMALS;
AUTOIMMUNE DISEASES;
BRAIN;
CENTRAL NERVOUS SYSTEM;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
INFLAMMATION;
NERVE DEGENERATION;
NERVOUS SYSTEM DISEASES;
PEPTIDES;
|
|
EID: 38449106357
PISSN: 08937648
EISSN: None
Source Type: Journal
DOI: 10.1007/s12035-007-8002-z Document Type: Review |
|
Times cited : (35)
|
|
References (70)
|
